ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 152

Subclinical Synovial Inflammation in Gout

Priya Chowalloor1,2, Patrick Cheah3 and Helen I. Keen1,2, 1Rheumatology, Royal Perth Hospital, Perth, Australia, 2School of Medicine and Pharmacology, The University of Western Australia, Crawley, Australia, 3Rheumatology, Sir Charles Gairdner Hospital, Nedlands, Australia

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: C Reactive Protein, gout, Synovitis, ultrasonography and uric acid

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Imaging of Rheumatic Diseases: Ultrasound

Session Type: Abstract Submissions (ACR)

Background/Purpose

Gout is poorly managed in the community. Long standing poorly controlled gout can lead into progressive destructive arthropathy, decreased quality of life and increased mortality. Aims of this study is to assess the burden of subclinical synovitis in gout both in acute and intercritical phases. Subclinical synovitis may have implications for the long term outcome of patients with gout.

Methods

This pilot study included 30 participants with gout according to either ACR or EULAR criteria. Subjects with any other inflammatory joint disorders were excluded. Subjects were examined twice. One visit was during the period of acute gout and second was during the intercritical phase. The intercritical phase visit was done at least four weeks after the resolution of symptoms of acute gout. Examinations performed during each visit include tender and swollen joint count, musculoskeletal ultrasound (US) of 52 peripheral joints for gray scale synovitis and power Doppler (PD). Blood was collected for ESR, high sensitivity CRP (hs CRP) and uric acid.

Results

Median age of the subjects was 69 (IQR 52.5-74) and BMI was 26.40(IQR 23.12-29.40). Females were 7.4%. Median disease duration was 3 years (IQR 11-2). The mean interval between visits was 3.6 months (SD 2.4).

 

Flare visit

Intercritical visit

P value

Number of subjects seen

27

27

 

Hs CRP

8.19 (3.57-37.45)*

5.15 (1.39-8.46)*

0.054

ESR

28 (14.5-44.75)*

13.5 (5.75-33)*

0.031

Serum uric acid

0.44 (0.36-0.5)*

0.38 (0.2975-0.485)*

0.405

Number of joints clinically involved

1 (1-2)*

0 (0-0)*

0.007

Number of joints involved on US (defined as a PD score of >/= 2)

5 (3-11)*

4 (3-7)*

0.139

Number of joints involved only by US and not clinically

4 (2-9)*

4.5 (3-7.25)*

0.901

Most commonly involved joints by US

 

1st MTP (n=30), knee (n= 17), wrist (n=17) and 2nd MCP (n=16)

 

1st MTP (n=21), wrist (n= 17),

2nd MCP(n=17) and knee (n=14)

 

 

*Median (IQR)

Conclusion

Ultrasound demonstrates subclinical synovitis during acute and intercritical periods. Interestingly, whilst there were significantly less clinically active joints during the intercritical period (p =0.007) there was not less joints involved by US (p=0.139). Ultrasound may be important in the monitoring of inflammation in the management of gout.


Disclosure:

P. Chowalloor,
None;

P. Cheah,
None;

H. I. Keen,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/subclinical-synovial-inflammation-in-gout/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology